Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Using 5-aminolevulinic acid photodynamic therapy for hair loss didn't increase hair growth but slightly reduced scalp oiliness, and it was safe with mild side effects.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Apremilast showed mixed results for treating severe alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Leukemia can sometimes appear as unusual skin issues in children.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Ruxolitinib cream may help treat severe hair loss in children.